SCHEMBL7966481

SCHEMBL7966481

C1=Cc2ccoc2CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14591132 0.76
SCHEMBL18602818 0.71 CA1 (0.34)
SCHEMBL2706443 0.68 CA1 (0.32)
SCHEMBL3628864 0.68
SCHEMBL11737334 0.67
SCHEMBL8385481 0.64
SCHEMBL31129123 0.64
SCHEMBL18726373 0.62 HSP90AA1 (0.31)
SCHEMBL18290393 0.62 HSP90AA1 (0.31)
SCHEMBL5796683 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109651291-B Polysubstituted naphtho [1,2-d ] thiazole and derivative and synthesis method thereof 广东蓝天优创美化妆品有限公司 2023-07-07 CN claimed
CN-109651291-A A kind of polysubstituted naphtho- [1,2-d] thiazole and derivative and its synthetic method 湘潭大学 2019-04-19 CN claimed
WO-2026098560-A2 BENZENE-CONTAINING POLYCYCLIC DERIVATIVE MODULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2026-05-15 WO disclosed
CN-119775353-A Short peptide compound and preparation method thereof, cosmetic composition and application 常州市智态生创科技有限公司 2025-04-08 CN disclosed
US-20250011330-A1 Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors LEIDOS BIOMEDICAL RESEARCH INC. 2025-01-09 US disclosed
CN-116514799-A Wee1 inhibitor, composition and application thereof 星希尔生物科技(上海)有限公司 2023-08-01 CN disclosed
CN-109651291-B Polysubstituted naphtho [1,2-d ] thiazole and derivative and synthesis method thereof 广东蓝天优创美化妆品有限公司 2023-07-07 CN disclosed
EP-3630759-A1 ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT Centre National De La Recherche Scientifique (FR) 2020-04-08 EP disclosed
CN-110357875-A Azabicyclo-octane analog derivative, preparation method and its purposes in medicine 浙江海正药业股份有限公司 2019-10-22 CN disclosed
CN-109689647-A The compound that bicyclic heteroaryl replaces 百时美施贵宝公司 2019-04-26 CN disclosed
CN-109651291-A A kind of polysubstituted naphtho- [1,2-d] thiazole and derivative and its synthetic method 湘潭大学 2019-04-19 CN disclosed
US-20140135400-A1 NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR METABASIS THERAPEUTICS, INC. (US) 2014-05-15 US disclosed
US-20140135400-A1 NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR METABASIS THERAPEUTICS, INC. (US) 2014-05-15 US disclosed
WO-2013087581-A1 AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-06-20 WO disclosed
US-20120209005-A1 FUSED HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-08-16 US disclosed
WO-2009144395-A1 POLYSUBSTITUTED DERIVATIVES OF 2-HETEROARYL-6-PHENYL-IMIDAZO[L,2- Α] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-12-03 WO disclosed
EP-1694659-B1 THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS SCHERING CORP (US) 2008-08-27 EP disclosed
US-7283372-B2 Circuit element having a first layer of an electrically insulating substrate material and method for manufacturing a circuit element INFINEON TECHNOLOGIES AG (DE) 2007-10-16 US disclosed
EP-1484327-B1 NITROGENOUS HETEROCYCLIC COMPOUND AND MEDICINE THEREOF EISAI R&D MAN CO LTD (JP) 2007-08-01 EP disclosed
US-4933265-A NUCLEATION PROMOTER FUJI PHOTO FILM CO., LTD. (JP) 1990-06-12 US disclosed